Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ignite Proteomics
Golden, Colorado, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Ignite Proteomics offers the only commercially available CLIA‑validated assay measuring expression and activation of cancer drug targets, outperforming genomic profiling in predicting and guiding therapy, particularly in breast cancer. In a metastatic breast cancer cohort, RPPA-based protein activation analysis better predicted therapeutic response than genomic testing alone[2][5].
- Therapeutic areas
- Oncology
- Modalities
- Diagnostic assayProtein biomarker assayReverse Phase Protein Array-based assay
- Industry
- Protein Biomarker Diagnostics
02
Partnerships
Inova Health (precision oncology/late-stage GI cancer biomarker study)[7]Perthera (clinical research coordination in breast cancer)[2]
Beyond the preview
Go deeper on Ignite Proteomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ignite Proteomics.